Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Büschenfelde K H, Boon T
I. Medizinische Klinik und Poliklinik, Johannes Gutenberg-Universität, Mainz, FRG.
Eur J Immunol. 1994 Mar;24(3):759-64. doi: 10.1002/eji.1830240340.
A number of cytolytic T lymphocyte (CTL) clones derived from several melanoma patients have been found to recognize a majority of melanomas from HLA-A2 patients. We have reported previously that two such CTL clones recognize a product of the tyrosinase gene that is presented by HLA-A2. Here we show that one of these CTL clones recognizes a peptide encoded by the first nine amino acids of the putative signal sequence of tyrosinase. The other CTL clone recognizes a different tyrosinase peptide corresponding to amino acids 368-376. Both peptides contain consensus motifs of HLA-A2 binding peptides.
从多名黑色素瘤患者中获得的一些细胞毒性T淋巴细胞(CTL)克隆已被发现可识别大多数来自HLA - A2患者的黑色素瘤。我们之前曾报道,两个这样的CTL克隆可识别由HLA - A2呈递的酪氨酸酶基因产物。在此我们表明,其中一个CTL克隆识别由酪氨酸酶假定信号序列的前九个氨基酸编码的肽段。另一个CTL克隆识别对应于氨基酸368 - 376的不同酪氨酸酶肽段。这两种肽段都包含HLA - A2结合肽的共有基序。